Ireland
--:--IST
Latest
Clinical Trials in Italy / NCT04299984
Recruiting Observational

Italian Multicenter Database for Open Conversions After EVAR

NCT04299984 · tracked via the Priya Life Science Italy tracker
Phase
Observational
Started
2022-01-01
Last updated
2025-06-04

Condition(s) studied

Abdominal Aortic AneurysmAbdominal Aortic Aneurysm Enlargement

Investigational drug(s) / intervention(s)

Open Conversion after EVARSemiConversion after EVAR

Open Conversion after EVAR: See "Open Conversions" group description.

SemiConversion after EVAR: See "SemiConversions" group description.

Study summary

Late endovascular abdominal aneurysm repair (EVAR) complications not amenable to endovascular correction can undergo either late open conversion (LOC) or semi-conversion (SC).

LOC is defined as a total or partial endograft explantation \>30 days after the initial EVAR.

SC is defined as open or laparoscopic surgery for endoleak (EL) correction with complete endograft preservation.

The aim of this study is to collect in a prospective database the technical aspects of a multicenter experience of LOC and SC, and to analyse early and long-term outcomes of these two treatments.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * open or laparoscopic surgery for EVAR complications, with or without endograft explantation Exclusion Criteria: * endovascular reinterventions * extra-anatomical bypass surgery (e.g. femoro-femoral crossover bypass) not associated with direct aorta/endograft surgery

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Azienda Ospedaliero-Universitaria di Parma Parma Italy Recruiting

More Azienda Ospedaliero-Universitaria di Parma trials in Italy

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04299984 on ClinicalTrials.gov ↗ ← All trials in Italy